Log in using OpenID

Bioburden Testing Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2015 - 2023

Bioburden is defined as the number in terms of percentage, colony or cell count of bacteria that thrive on a given unsterilized surface. Bioburden testing, also known as microbial limit testing provides quantification of the bacterial cell cultures
Single User License:
Bioburden Testing Market - Global
Industry Analysis, Size, Share,
Growth, Trends And Forecast 2015 2023
USD 4315.5
Transparency Market Research
State Tower,
90, State Street, Suite 700.
Albany, NY 12207
United States
[email protected]
Flat 10% Discount!!
Free Customization as per your requirement
You will get Custom Report at Syndicated Report
Report will be delivered with in 15-20 working days
Request Sample
Buy Now
Bioburden is defined as the number in terms of percentage, colony or cell count of bacteria that thrive on a given
unsterilized surface. Bioburden testing, also known as microbial limit testing provides quantification of the bacterial
cell cultures on a given unsterilized surface. The major application of bioburden testing lies in implant fixation
procedures that require testing ofcertain tolerable bioburden limit before implantation in the human body. The
standard for bioburden testing in the US is regulated by the US FDA, whereas global standards are maintained by the
ISO (International Organization for Standardization). The quantification for the standardization process is done in
terms of colony forming unit (CFU).
Browse Full Report with TOC @
Bioburden testing is essential in limiting the presence of infection causing bacteria in an object that is to be
integrated into a human body as an implant. The testing is important to eliminate the presence of bacterial residue
and growth in any object present in natural state. In addition it is almost impossible to remove bacterial residue
permanently in an object that is liable to be exposed to open air. Hence sterilization process is performed on an
implant object or a device post understanding the bioburden limit. This helps to select the appropriate sterilization
technique in order to remove the bacterial burden just prior to the medical (Or other related) procedure. Bioburden
testing has therefore saved numerous lives.
Based on technology, bioburden testing is segmented into microbial filter method, advanced colorimetric method,
and plate count method. Among these, microbial filter method is the most commonly used method for bioburden
testing procedures. The plate count method is among the oldest methods for bioburden testing, however is not used
regularly on a large scale commercial basis due to its time consuming procedure. Advanced colorimetric method is
presently the most promising and widely used bioburden testing technology. The congregation of colometer and
computational capabilities has enabled advanced colometric methods to deliver quick results of quantifying
Based on equipment, bioburden testing market can be segmented into PCR (polymerase chain reaction)
instruments, cell counters, and automated microbial identification systems that are software integrated. Application
segment for bioburden testing includes healthcare, aerospace (satellite production & development), supercomputer
(super- microprocessor manufacturing) designing, and others (raw material, equipment cleaning, food & beverage).
The healthcare industry is the largest application area of bioburden testing.
Geographically, the bioburden testing market is primarily concentrated in the North America and Asia Pacific region.
The demand for bioburden testing in the Asia Pacific region is expected to grow, and very likely to replace the North
America market soon. Australia, Japan, and China form the largest markets in the Asia Pacific region. South Asia and
South East Asia on the other hand show great potential in terms of life sciences and raw material applications;
although at present a majority of the growing bioburden testing market consists of life science applications. Besides
this, a large number of contract manufacturers reside in the Asia Pacific region. On the other hand, European
industries continue to remain a strong point in the global bioburden testing market mainly due to the high quality of
products services offered, presence of numerous quality manufacturers and their increased reliability. However
certain significant restrictions for bioburden testing remains valid in the European and North American region, such
as dearth of trained technicians, overwhelming volume of service demand, and high cost of services, to name a few.
The bio-burden testing market in the Rest of the World (ROW) region is expected to grow at a steady rate, albeit
slower than the major economies of the world.
Some of the well known manufacturers/service providers of bioburden testing equipment/service include: Charles
River Laboratories International, Inc., Sigma-Aldrich Corporation, SGS S.A., WuXi PharmaTech (Cayman), and Inc.,
Merck & Co., Inc., Becton, Dickinson and Company, North American Science Associates, Inc., Nelson Laboratories,
Pacific Biolabs, and ATS Labs, Inc.
This research report analyzes this market on the basis of its market segments, major geographies, and current
market trends. Geographies analyzed under this research report include
North America
Asia Pacific
Middle East and Africa
Latin America
This report provides comprehensive analysis of
Market growth drivers
Factors limiting market growth
Current market trends
Market structure
Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides
market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five
force model analysis and detailed profiles of top industry players. The report also includes a review of micro and
macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
Inquiry Before Buying:
Latest Press Release Reports:
Latest Articles Reports:
Read More Reports on Biotechnology Market:
About Us
Transparency Market Research (TMR) is a market intelligence company providing global business research
reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis
provides forward-looking insights for thousands of decision-makers.
TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with
various tools and techniques to gather and analyze information. Our business offerings represent the latest
and the most reliable information which is indispensable for businesses to sustain their competitive edge.
Transparency Market Research
90 State Street,
Suite 700,
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: [email protected]
shekharm18   documents Email
technical documentation
File Size
129 KB
Report inappropriate content